BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27608975)

  • 1. Salivary psoriasin (S100A7) correlates with diffusion capacity of carbon monoxide in a large cohort of systemic sclerosis patients.
    Giusti L; Sernissi F; Donadio E; Ciregia F; Giacomelli C; Giannaccini G; Mazzoni MR; Lucacchini A; Bazzichi L
    J Transl Med; 2016 Sep; 14(1):262. PubMed ID: 27608975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement?
    Baldini C; Giusti L; Bazzichi L; Ciregia F; Giannaccini G; Giacomelli C; Doveri M; Del Rosso M; Bombardieri S; Lucacchini A
    J Rheumatol; 2008 Sep; 35(9):1820-4. PubMed ID: 18634149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis.
    Takahashi T; Asano Y; Yamashita T; Nakamura K; Saigusa R; Miura S; Ichimura Y; Toyama T; Hirabayashi M; Taniguchi T; Yoshizaki A; Sato S
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):291-297. PubMed ID: 28681537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis.
    Giusti L; Bazzichi L; Baldini C; Ciregia F; Mascia G; Giannaccini G; Del Rosso M; Bombardieri S; Lucacchini A
    J Rheumatol; 2007 Oct; 34(10):2063-9. PubMed ID: 17722226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection.
    Andresen E; Lange C; Strodthoff D; Goldmann T; Fischer N; Sahly H; Branscheid D; Heine H
    BMC Pulm Med; 2011 Feb; 11():10. PubMed ID: 21324122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide.
    Pernot J; Puzenat E; Magy-Bertrand N; Manzoni P; Gondouin A; Bourdin H; Simon-Rigaud ML; Regnard J; Degano B
    Respiration; 2012; 84(6):461-8. PubMed ID: 22301769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human β-defensins and psoriasin/S100A7 expression in salivary glands: anti-oncogenic molecules for potential therapeutic approaches.
    Kesting MR; Stoeckelhuber M; Kuppek A; Hasler R; Rohleder N; Wolff KD; Nieberler M
    BioDrugs; 2012 Feb; 26(1):33-42. PubMed ID: 22149099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
    Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
    Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
    Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
    Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Biomarkers in Systemic Sclerosis Disease.
    Zian Z; Bakkach J; Barakat A; Ghailani Nourouti N; Bennani Mechita M
    Biomed Res Int; 2018; 2018():3921247. PubMed ID: 29721505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
    Moinzadeh P; Krieg T; Hellmich M; Brinckmann J; Neumann E; Müller-Ladner U; Kreuter A; Dumitrescu D; Rosenkranz S; Hunzelmann N
    Exp Dermatol; 2011 Sep; 20(9):770-3. PubMed ID: 21707759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine concentrations in exhaled breath condensates in systemic sclerosis.
    Edmé JL; Tellart AS; Launay D; Neviere R; Grutzmacher C; Boulenguez C; Labalette M; Hachulla E; Hatron PY; Dessaint JP; Matran R; Sobaszek A
    Inflamm Res; 2008 Apr; 57(4):151-6. PubMed ID: 18351434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum levels of nitrotyrosine, a marker for peroxynitrite production, in systemic sclerosis.
    Shimizu K; Ogawa F; Muroi E; Hara T; Komura K; Bae SJ; Sato S
    Clin Exp Rheumatol; 2007; 25(2):281-6. PubMed ID: 17543154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis.
    Trad S; Huong du LT; Frances C; Wechsler B; Cacoub P; Costedoat N; Haroche J; Piette JC; Hanslik T; Amoura Z
    Eur J Intern Med; 2011 Dec; 22(6):e80-6. PubMed ID: 22075318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis.
    Awad SM; Attallah DA; Salama RH; Mahran AM; Abu El-Hamed E
    Clin Exp Dermatol; 2018 Apr; 43(3):262-267. PubMed ID: 29333662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung involvement in systemic sclerosis].
    Quadrelli S; Ciallella L; Catalán Pellet AC; Molinari L; Salvado A; Auad C; Spina JC
    Medicina (B Aires); 2007; 67(5):429-35. PubMed ID: 18051224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Mod Rheumatol; 2012 Sep; 22(5):668-75. PubMed ID: 22160844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
    Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
    BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.